Latest News & Features
Americas
In 2007, Robin Roberts, co-anchor for ABC News’s Good Morning America show, was diagnosed with breast cancer. Five years later, she was diagnosed with myelodysplastic syndrome, a disease of the blood and bone marrow once known as pre-leukaemia. 6 June 2018
Americas
Why has the US Supreme Court never granted certiorari on the issue of differing standards required to prove patent invalidity at district courts and at the US Patent and Trademark Office (USPTO)? 6 June 2018
Americas
“It is my firm belief that folks on all sides need to stop relentlessly bashing the [patent] system if they want it to succeed.” 5 June 2018
Asia
India’s Drug Technical Advisory Board, which advises the government, has reportedly approved a “track and trace” proposal that will allow Indian consumers to identify whether their medicine is genuine simply by sending a text message. 4 June 2018
Big Pharma
The Paris Court of First Instance has nullified a supplementary protection certificate covering Gilead’s HIV/AIDS treatment Truvada. 4 June 2018
Americas
The US International Trade Commission announced yesterday that it will investigate certain blood cholesterol testing systems and strips after receiving a complaint from Polymer Technology System. 1 June 2018
Africa
Médecins Sans Frontières has welcomed the South African government’s release of a new IP policy, calling it an effort to take off a “patent blindfold”. 1 June 2018
Asia-Pacific
A court has rejected an appeal by the Australian Competition and Consumer Commission, in a decision which confirmed that deals made by Pfizer in relation to generic cholesterol-lowering medication do not constitute a misuse of its market power. 31 May 2018
Americas
Takeda and Aurobindo have agreed to dismiss a dispute over Aurobindo’s filing of an Abbreviated New Drug Application (ANDA) for a generic version of Prevacid Solutab (lansoprazole). 31 May 2018
Asia-Pacific
UK-based Crescendo Biologics has agreed a global licensing deal with biopharma company Zai Lab which will see Zai Lab develop and commercialise an antibody, “VH domain therapeutic”, for applications in inflammatory diseases. 31 May 2018